Table 2.
Antibiotic resistance profiles of the clinical isolates used in the study [20].
| Antibiotic Resistance Profile of the Clinical Isolated Bacteria | ||
|---|---|---|
| Antibiotics | MIC (mg/L) | Interpretation |
| S. aureus MS | ||
| Fusidic acid | 0.5 | S |
| Daptomycin | 0.25 | S |
| Erythromycin | 0.25 | S |
| Fosfomycin | 8 | S |
| Gentamicin | 0.5 | S |
| Linezolid | 2 | S |
| Levofloxacin | 0.12 | S |
| Oxacillin | 0.25 | S |
| Teicoplanin | 0.5 | S |
| Tetracycline | 1 | S |
| Tigecycline | 0.12 | S |
| Trimethoprim/sulfamethoxazole | 10 | S |
| Vancomycin | 0.5 | S |
| Penicillin | 0.03 | S |
| S. aureus MDR | ||
| Fusidic acid | 0.5 | S |
| Daptomycin | 0.25 | S |
| Erythromycin | 4 | R |
| Fosfomycin | 64 | R |
| Gentamicin | 8 | R |
| Linezolid | 2 | S |
| Levofloxacin | 8 | R |
| Oxacillin | 2 | R |
| Teicoplanin | 0.5 | S |
| Tetracycline | 1 | S |
| Tigecycline | 0.12 | S |
| Trimethoprim/sulfamethoxazole | 20 | S |
| Vancomycin | 0.5 | S |
| Penicillin | 0.25 | R |
| Rifampicin | 2 | R |
| E. faecalis MS | ||
| Ampicillin | 2 | S |
| Gentamicin/syn | 500 | S |
| Imipenem | 2 | S |
| Linezolid | 2 | S |
| Teicoplanin | 0.5 | S |
| Tigecycline | 0.25 | S |
| Vancomycin | 2 | S |
| Cefuroxime | 64 | R |
| E. faecalis MDR | ||
| Ampicillin | 8 | R |
| Gentamicin/syn | 500 | R |
| Imipenem | 8 | R |
| Linezolid | 2 | S |
| Teicoplanin | 0.5 | S |
| Tigecycline | 0.25 | R |
| Vancomycin | 2 | S |
| E. coli MS | ||
| Amikacin | 2 | S |
| Amoxicillin/clavulanate | 2 | S |
| Ampicillin | 8 | S |
| Cefepime | 1 | S |
| Cefotaxime | 1 | S |
| Ceftazidime | 1 | S |
| Cefuroxime | 4 | S |
| Ciprofloxacin | 0.25 | S |
| Ertapenem | 0.5 | S |
| Fosfomycin | 16 | S |
| Gentamicin | 1 | S |
| Imipenem | 0.25 | S |
| Levofloxacin | 0.5 | S |
| Meropenem | 0.25 | S |
| Piperacillin | 8 | S |
| Piperacillin/tazobactam | 4 | S |
| Tobramycin | 1 | S |
| Trimethoprim/sulfamethoxazole | 20 | S |
| Tigecycline | 0.5 | S |
| E. coli MDR | ||
| Amikacin | 16 | R |
| Amoxicillin/clavulanate | 32/2 | R |
| Ampicillin | 8 | R |
| Cefepime | 8 | R |
| Cefotaxime | 4 | R |
| Ceftazidime | 8 | R |
| Cefuroxime | 8 | R |
| Ciprofloxacin | 1 | R |
| Ertapenem | 0.25 | R |
| Fosfomycin | 16 | R |
| Gentamicin | 4 | R |
| Imipenem | 0.25 | R |
| Levofloxacin | 2 | R |
| Meropenem | 0.125 | R |
| Piperacillin | 16 | R |
| Piperacillin/tazobactam | 16/4 | R |
| Tobramycin | 4 | R |
| Trimethoprim/sulfamethoxazole | 1/19 | R |
| Tigecycline | 1 | R |
| K. pneumoniae MS | ||
| Ciprofloxacin | 0.25 | S |
| Fosfomycin | 16 | S |
| Ampicillin | 1 | S |
| Gentamicin | 20 | S |
| Trimethoprim/sulfamethoxazole | 2 | S |
| Amikacin | 8 | S |
| Amoxicillin/clavulanate | 2 | S |
| Cefepime | 1 | S |
| Cefotaxime | 1 | S |
| Cefotaxime | 1 | S |
| Ertapenem | 0.5 | S |
| Imipenem | 0.25 | S |
| Meropenem | 0.25 | S |
| Piperacillin/tazobactam | 4 | S |
| Colistin | 0.5 | S |
| K. pneumoniae MDR | ||
| Ciprofloxacin | 4 | R |
| Fosfomycin | 64 | S |
| Ampicillin | 1 | S |
| Gentamicin | 320 | R |
| Trimethoprim/sulfamethoxazole | 64 | R |
| Amikacin | 32 | R |
| Amoxicillin/clavulanate | 8 | R |
| Cefepime | 64 | R |
| Cefotaxime | 64 | R |
| Cefotaxime | 64 | R |
| Ertapenem | 8 | R |
| Imipenem | 16 | R |
| Meropenem | 16 | R |
| Piperacillin/tazobactam | 128 | R |
| Colistin | 0.5 | S |